BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.
IVDR compliance is a critical milestone not only for regulatory readiness, but for the long-term sustainability of ...
The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION ...
Zacks Investment Research on MSN
BDX secures CE mark for Revello stent to treat iliac artery disease
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...
IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., an innovator of next generation respiratory technology, announced today that it has received CE (Conformité Européenne) Marking under the European ...
The UPC has granted a preliminary injunction effective for Germany, France, Italy, the Netherlands and Ireland against a Chinese medical device manufacturer and its Dutch subsidiary over the ...
Add Yahoo as a preferred source to see more of our stories on Google. PCOS affects between 10% and 13% of women worldwide. Image credit: Toey Andante via Shutterstock.com. (Toey Andante via ...
First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU This in vitro diagnostic (IVD) assay, which has been ...
Only a month after Getinge announced the suspension of the CE marks allowing it to sell its heart-lung support and permanent life support systems in Europe, the Swedish devicemaker has temporarily ...
Rockfield Medical Devices Limited Receives CE Mark Approval for the Mobility+® Enteral Feeding System, Marking a Major Milestone in Global Commercial Expansion ...
PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results